Latest News

Date Title Topic
19 Jun 2014 EMUC 2014: Abstract Submission Deadline: 1 July 2014
18 Jun 2014 Sedentary Behavior Increases the Risk of Certain Cancers Epidemiology/Etiology/Cancer Prevention
17 Jun 2014 View the Webcasts from the ESMO Preceptorship on Colorectal Cancer 2014
17 Jun 2014 Benefits of Trastuzumab for Advanced Breast Cancer Outweigh the Risk of Harm Breast cancer - Anticancer agents & Biologic therapy
13 Jun 2014 Rare Cancers Europe Consensus Statement
13 Jun 2014 Where Can We Find Savings in Health Care? Bioethics, legal and economic issues
10 Jun 2014 ESMO Press Release: ESMO Survey Sheds Light on Common Clinical Practice for Incompletely Resected Lung Cancer Lung and other thoracic tumours
10 Jun 2014 Phase III Study Strengthens Support of Ibrutinib as Second-line Therapy for CLL and SLL Haematologic malignancies - Anticancer agents & Biologic therapy
30 May 2014 New Guidelines for Planning and Developing Cancer Registries in Low- and Middle-Income Settings Epidemiology/Etiology/Cancer Prevention
28 May 2014 European Medicines Agency Adopted a Change to an Indication for Eribulin Anticancer agents & Biologic therapy
27 May 2014 European Medicines Agency Recommends to Extend Indications for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
26 May 2014 European Medicines Agency Recommends to Refuse a Change to the Marketing Authorisation for Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy